Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

UCB Launches Strategic Research Alliance with Weill-Cornell Medical College
Friday, April 04, 2014
Strategic collaboration commences with three discovery programs in areas of high patient need.

Charles River Laboratories Completes Acquisition of Galapagos’ CRO Services
Thursday, April 03, 2014
Acquisition is expected to add approximately 6% to Company’s net sales in 2014.

UCB CEO to Chair IMI Board for a Second Term
Wednesday, April 02, 2014
Roch Doliveux to spearhead industry’s commitment to world’s biggest public-private partnership in biopharmaceutical research and innovation.

Drug Developers Drawn to Orphan Drugs Market
Thursday, March 27, 2014
Breakthrough therapies for rare diseases command premium pricing, particularly if no alternatives exist.

Daiichi Sankyo Files NDA in Japan for Marketing of the Methylene Blue Injection Medicinal Product
Tuesday, March 25, 2014
Daiichi Sankyo will resolve the unmet need for an approved Methylene Blue injectable drug in Japan.

IDRI and Jubilant Chemsys Extend TB Research Partnership
Monday, March 24, 2014
Jubilant Chemsys announces extension of collaboration with Infectious Disease Research Institute for TB drug discovery.

Astellas Pharma and Daiichi Sankyo Form Compound Library Sharing Partnership
Saturday, March 22, 2014
Both Companies will exchange approximately 400,000 selected compounds.

New Trial of Personalized Cancer Treatment Begins in Oxford
Tuesday, March 18, 2014
Phase I trial in Oxford will investigate a new drug, called CXD101.

Purdue, Houston Methodist to Take Drug Discoveries from the Bench Top to the Bedside
Monday, March 17, 2014
The planned collaboration on research and educational initiatives includes clinical trials of drugs developed at Purdue.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 3932
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to